O'Sullivan CC
No ORCID on file
· 1 paper in corpus
other
2016
In this issue of The Oncologist, Agarwal et al. report negative results from a phase I trial of LFA102. Although “negative” in terms of antitumor activity, the study provides useful pharmacokinetic and pharmacodynamic information. Future tr…